Vacancysoft - Clinical Professionals - Pharmaceuticals Report, November 2015

VACANCYSOFTB u s i n e s s I n t e l l i g e n c e t h r o u g h V a c a n c y D a t a

Vacancysoft/Clinical Professionals Pharmaceuti cals Report

NOVEMBER 2015

GERMANY FOCUS


Clinical Page 03

Medical Page 04

QA Page 05

Biostats Page 06

About Clinical Professionals Page 07

About Vacancysoft Page 08

Contents

We are delighted to be partnering with Vacancysoft to provide insight on recruitment acti vity in the Pharmaceuti calssector.

For this report we have been analysing acti vity in Germany, identi fying key hotspots of acti vity we are witnessing.

I hope you fi nd it interesti ng and should you like to know more about current market acti vity please do contact me on yvett [email protected]

Yvett e ClelandCEOClinical Professionals


Clinical

During the 12 months to September 2015 Germany represented the second largest EEA market for scienti fi c vacancies with 20% of the total, second only to the UK with 28%.

Across the EEA as a whole Clinical roles comprised the largest segment with 22.8% of all vacancies. Interesti ngly this falls to 15% within the German market behind R&D and Quality Assurance. With an impressive monthly growth rate of 10.1%, however, this may well change over the coming year.

One of the most striking aspects of this strong growth is the rise of the CROs, which accounted for 59% of all vacancies. And with a monthly growth rate of 11.8%, compared to 8.1% for pharmaceuti cal companies, their dominance is likely to conti nue. Of the top 10 companies, representi ng 58% of the market, seven are now CROs. Parexel (number one), PRA (number two) and Quinti les (number three) lead the way accounti ng for over a quarter of vacancies.

In terms of specifi c roles Clinical Project positi ons top the list with 17% of vacancies aft er experiencing a steep rise since April this year driven by Quinti les and Covance. CRA roles make up the second largest with 14% followed by CRA II and CTA with 10% a piece.

The vast majority of vacancies, 82%, are at Mid and Senior levels but strong growth in Junior positi ons may indicate a subtle shift toward greater investment in in-house training and development of staff .

The clinical industry in Germany has seen a consistent requirement for CRAs following last year, but a decrease in available candidates. There has been an increase in Pre-Clinical roles, as companies look to uti lise the strong academic hubs in Germany. There have been a number of Project Leader roles working on ground-breaking research. There has been a slight increase in average salaries, with experienced Senior CRAs now looking for a minimum of €65 000. The freelance market is ti ghtening, with more people looking for permanent roles due to working legislati ons and requirements. Companies which do off er freelance opportuniti es are tending to look for candidates with 100% FTE availability.

JAN FEB MAR APR MAY JUN JUL AUG SEP

51 - 500 501 - 5000 5000 +

OCT

Tota

l Vac

anci

es

NOV DEC

CLINICAL OPERATIONS CTA CLINICAL PROJECTSSENIOR CRA CLINICAL DEVELOPMENT CRAOTHER (6 ROLES) CLINICAL DATA MANAGEMENT CRA II

2014 2015

40

60

50

80

70

10

20

30

Clinical Vacancies in Germany by Role

Clinical Vacancies in Germany by Company

Parexel International Corp

PRA Health Sciences Inc

Quintiles Inc

Bayer AG

INC Research LLC

ICON PLC

Hexal AG

Clinipace Worldwide Inc

Covance Inc

Novartis AG

Other (67 Companies)

Grand Total

HeadCountSectorCompany % Total

74

43

40

37

33

31

28

22

20

18

252

598

12.4%

7.2%

6.7%

6.2%

5.5%

5.2%

4.7%

3.7%

3.3%

3.0%

42.1%

100.0%

103

70

68

472

46

40

140

25

37

185

N/A

3955

CRO

CRO

CRO

Pharma

CRO

CRO

Pharma

CRO

CRO

Pharma

606

460

818

702

434

383

140

76

756

1095

N/A

19768

72%

61%

59%

8%

72%

78%

20%

88%

54%

10%

N/A

15%

12%

9%

5%

5%

8%

8%

20%

29%

3%

2%

N/A

3%

GrandTotal

GermanyScientific

% GermanyScientific

EEAScientific

% EEAScientific

OCTOBER 2014 - SEPTEMBER 2015


Medical

Roles in the Medical segment accounted for 7.9% of the German scienti fi c market in the year to September 2015, making it the fourth largest. Despite experiencing a relati vely weak fi nal month Medical vacancies experienced strong overall growth with a monthly growth rate of 7.1%, equivalent to 128% annually.

Medical Aff airs and Medical Advisor positi ons dominated the market with 48% and 41% respecti vely. Medical Aff airs experienced a parti cularly strong August driven by a surge of vacancies from Amgen, representi ng close to two-thirds (60%) of their total Medical vacancies for the year. Of these all were at a senior level perhaps suggesti ng the creati on of a new team or heavy investment into capabiliti es?

In terms of seniority in general Mid Associate/Manager level positi ons make up the majority with 67% of the total followed by Senior Associate/Manager with just under 20%. Interesti ngly Director and Department/Divisional Head vacancies make up a relati vely large proporti on, 12.4%, of which a quarter are from Merck Serono.

Other companies also investi ng heavily in the sector include Vifor with 75% of their German scienti fi c vacancies in Medical roles, Biogen with 56%, UCB with 43% and GSK with 33%.

JAN FEB MAR APR MAY JUN JUL AUG SEPOCT

Tota

l Vac

anci

es

NOV DEC

MEDICAL COMMUNICATIONS MEDICAL AFFAIRSLIBRARIAN MEDICAL ADVISORSCIENTIFIC ADVISOR MEDICAL INFORMATION

2014 2015

40

50

60

10

20

30

Medical Vacancies in Germany by Role

Roles Seniority

MEDICAL AFFAIRS

LIBRARIAN

MEDICAL INFORMATION

MEDICAL ADVISOR

SCIENTIFIC ADVISOR

MEDICAL COMMUNICATIONS

MID ASSOCIATE/MANAGER

DEPARTMENT/DIVISIONAL HEAD

DIRECTOR/PARTNER

SENIOR ASSOCIATE/MANAGER

JUNIOR ASSOCIATE/MANAGER


We have seen an increase in the volume of positi ons available for physicians in the German market during 2015, parti cularly within Medical Aff airs. The seniority of these positi ons have mainly been mid-level – up to Senior Associate/Manager. This growth has created a need for some of the more imminent roles to be managed on a contract/consultant basis to off ercompanies with a swift soluti on while recruitment is ongoing. We imagine this growth in Germany will conti nue for the next 6 months.


QA

Quality Assurance vacancies represented the second largest segment of the German market with 22.7% of all scienti fi c vacancies. Across the EEA as a whole QA roles experienced a steady 3.8% monthly growth rate, equivalent to an annual rate of 56%. Germany, however, saw weaker performance with 2.9% and 40% respecti vely.

Much of this weak performance can be att ributed to Quality Assurance (as a subset role), which, although accounti ng for the largest proporti on of vacancies, 43%, saw negligible monthly growth of just 0.3%. Quality Control positi ons, accounti ng for 26% of the total, fared slightly bett er with 3.7%. Out of the leading roles only Compliance saw a signifi cant increase substanti ally outperforming the European market.

Mid Associate/Manager level vacancies made up the majority of positi ons with over three-quarters (77%) of the total followed by Senior and Junior Associate/Manager level with 9% and 6% respecti vely. Interesti ngly Director and Divisional/Department Head vacancies saw a marked decline perhaps indicati ng the maturity of the market in Germany.

F Hoff mann-La Roche, Bayer and Novarti s topped the market, which combined, accounted for just over one quarter (27%) of all vacancies. Of these only Bayer, as a proporti on of their German scienti fi c vacancies, fell below the nati onal average with just 18% of their positi ons in QA.

We are not surprised at this data generally, there appears to be a stabilising eff ect in respect of demand across the German market which therefore explains the lack of decent growth in comparison to other sectors. I would however single out the growth in Compliance. We have noti ced increasing and more frequent demand in Compliance related vacancies and therefore this is obviously following a trend across other markets.

JAN FEB MAR APR MAY JUN JUL AUG SEPOCT

Tota

l Vac

anci

es

NOV DEC

QP

QP

QUALITY CONTROL

QUALITY CONTROL

AUDITOR

AUDITOR

COMPLIANCE

COMPLIANCE

OTHER (12 ROLES) VALIDATION

VALIDATION

QUALITY ASSURANCE

QUALITYASSURANCE

2014 2015

40

60

120

80

100

20

QA Vacancies in Germany by Role

Monthly Growth Rate of Leading QA Roles

EEAGERMANY

5%

6%

9%

7%

8%

4%

2%

3%

1%



Biostats

Accounti ng for just 3.8% of the German market Biostats experienced the fastest growth of any segment with monthly vacancies increasing roughly fi ve-fold over the year to September 2015, a monthly growth rate of 15.3%. This was well above the almost equally impressive 10.7% seen across the broader EEA market.

Bioanalyti cs and Biostati sti cian roles were the key drivers with 42% and 39% of vacancies with the remaining made up of Stati sti cs (17%) and Biometricians (2%).

In terms of seniority Mid Associate/Manager positi ons made up the majority with 66% of the total. Senior Associate/Manager level vacancies accounted for a further 25%. Low fi gures for both Junior and top-level positi ons suggest that most companies are looking to invest heavily in the fi eld by bulking up their existi ng capabiliti es.

Bayer is the market leader with 25% of vacancies followed by Sanofi Aventi s with 10.5% and Boehringer Ingelheim with 6.6%. Interesti ngly it’s not just the large pharmaceuti cal companies recruiti ng; accounti ng for over 10% of all vacancies CROs are also investi ng, parti cularly Inventi v Health Clinical with over 20% of their scienti fi c vacancies in Biostats roles.

The Biostati sti cs market has seen a high demand for Senior & Principal level applicants over the past year. However as ti me has progressed, there has been a decline in the availability of suitable candidate with the required skills. Also we’ve noti ced a trend with some Biotech and SME Pharmas making hybrid roles of diff erent functi ons – an example would be “Data Analyst Stati sti cian Medical Writer”. There’s been a slight increase in salary expectati ons, most candidates are seeking minimum salaries of around €70 000 at Senior level and €80 000 at Principal level. Most companies are refraining from using contractors in favour of outsourcing work to Stati sti cal Consultancies, much in the same manner as CROs. This has led to a decline in the amount of available contract positi ons and many contractors looking for permanent employment.

2014 2015

10

20

15

30

25

5

JAN FEB MAR APR MAY JUN JUL AUG SEP

51 - 500 501 - 5000 5000 +

OCT

Tota

l Vac

anci

es

NOV DEC

STATISTICS BIOANALYTICSBIOMETRICIAN BIOSTATISTICIAN

Biostats Vacancies in Germany by Role

Biostats Vacancies in Germany by Company

Bayer AG

Sanofi Aventis

Boehringer Ingelheim

AbbVie

Hexal AG

F Hoffmann-La Roche

Inventiv Health Clinical

Merck Serono Ltd

Eurofins Scientific

Medac GmbH

Other (24 Companies)

Grand Total

HeadCountSectorCompany % Total

38

16

10

9

9

7

7

7

5

5

39

152

25.0%

10.5%

6.6%

5.9%

5.9%

4.6%

4.6%

4.6%

3.3%

3.3%

25.7%

100.0%

472

147

161

111

140

280

32

218

104

48

N/A

3955

Pharma

Pharma

Pharma

Pharma

Pharma

Pharma

CRO

Pharma

CRO

Pharma

702

191

224

213

140

1074

164

444

233

48

N/A

19768

8.1%

10.9%

6.2%

8.1%

6.4%

2.5%

21.9%

3.2%

4.8%

10.4%

N/A

3.8%

5%

8%

4%

4%

6%

1%

4%

2%

2%

10%

N/A

1%

GrandTotal

GermanyScientific

% GermanyScientific

EEAScientific

% EEAScientific


Clinical ProfessionalsClinical Professionals is Europe’s leading independent life science staffing business offering outsourced solutions via Functional Service Provision (FSP) and traditional, high quality staffing solutions. Detailed market research carried out in early 2013 found that 95% of hiring managers rate Clinical Professionals as consistently superior in quality, speed of response, staff retention and communication. In addition to this, nine out of ten customers rate the company as their most trusted partner. Clinical Professionals have developed a highly comprehensive understanding of a broad range of specialist functional disciplines within the pharmaceutical industry. Our knowledge-base has its foundations in an unrivalled blend of industry experience combined with a commitment to investing in training and development. We have specialist teams dedicated to recruiting within the various pharmaceutical sectors for permanent, contract, interim, FSP and freelance vacancies. Clinical Professionals offer a variety of services for both candidates and clients, including our CP FSP model, offering clients the opportunity to outsource the recruitment of a whole team whilst retaining control of the monitoring function in-house.

What we do:Our Service Capabilities across all European Countries include:• Contingency permanent recruitment• Contract recruitment – freelance and PAYE via Clinical Professionals/Only Medics• Search and selection permanent recruitment• Specialist ‘project-based’ interims via Clinical Professionals/Only Medics• FSP outsourced teams across Europe

Clinical Professionals has launched their 2015 European Salary Survey to determine the salary and benefits for each sector of the UK Life Science industry.The Survey will analyse salary and benefits for each sector of the European Life Science industry, and follows on from the success of our previous pharmaceutical salary surveys.

Contact us for more information on [email protected]

EU OfficeGround Floor,

11-12 Bouverie Street,London, EC4Y 8DP

t | +44 (0)207 822 1710

UK Office33 Blagrave Street,Reading, Berkshire,

RG1 1PWt | +44 (0)118 959 4990

About Us• Launched in 2006, we provide Business Intelligence through Vacancy Data on subscripti on.

• We publish vacancy data daily, tailored to your needs, so you can be informed of client acti vity.

• Primarily used by recruiters, our service enables consultants to have a rapid response when Organizati ons post jobs thus facilitati ng Business Development and Client Management.

• Our data sets are also used by Executi ve Search, Consulti ng Firms, Business Services and Strategy Managers to facilitate a more client centric approach.

• For more informati on about us pleasecontact James Chaplin by email:james.chaplin@vacancysoft .com

Free Trial• On a daily basis we monitor over 500,000 companies for change.

• We confi gure an account for you with fi lters matching your needs. (So you decide which roles, sectors, locati ons you want to be kept informed about)

• You start getti ng daily emails from us with all relevant vacancy data.

• You also get an access to our online database, enabling you to search all acti vity in the market meeti ng your needs.

• Aft er you decide which data packages you want our unit based pricing means so you only pay for what you fi nd adds value.

• To set up your free trial today contact support@vacancysoft .com

Vacancysoft LLP is a limited liability partnership.Registered in England and Wales.Partnership no. OC327354.

Registered offi ce: Vicarage House, 58-60 Kensington Church St, London, W8 4DBVAT: GB 886 1961 74


Documents

Vacancysoft - Clinical Professionals - Pharmaceuticals Report, November 2015